Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | P2 - Poster Session 2

Sunday 04/26/20
08:00 AM - 09:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Sleep, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology
0.00 credit
Event Timeline
08:00 AM - 09:00 AM Abstract 9-001 - Characterization of Whole Brain Axonal Pathology in Multiple Sclerosis Using High-Gradient Diffusion MRI
Susie Y. Huang, MD, PhD
08:00 AM - 09:00 AM Abstract 9-002 - Identifying The Role Of A Hippocampal-thalamic Memory Network In Ms Using A Machine Learning Approach
Korhan Buyukturkoglu, PhD
08:00 AM - 09:00 AM Abstract 9-003 - Cognitive Impairment in Multiple Sclerosis: A Multiparametric Structural and Functional MRI Study
Carmen Vizzino
08:00 AM - 09:00 AM Abstract 9-004 - Evaluating the Performance of an Atlas-Free Automated Method of Brain Classification for Lesion Segmentation in Progressive Multifocal Leukoencephalopathy
08:00 AM - 09:00 AM Abstract 9-005 - Characterizing Dynamic Functional Connectivity in the Main Clinical Phenotypes of Multiple Sclerosis
Milagros Hidalgo de la Cruz
08:00 AM - 09:00 AM Abstract 9-006 - Diffusion Tensor Imaging of the Nucleus Basalis of Meynert Reveals Associations with Cognitive State in Patients with Multiple Sclerosis
Niels Bergsland
08:00 AM - 09:00 AM Abstract 9-007 - MS Subjects with Vascular Disease Risk Factors (VDRF) Show Persistent Dysmetabolism in Brain Phosphate Metabolites and Brain Volume Loss
Vijayshree Yadav, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 9-008 - Long-standing Multiple Sclerosis Neurodegeneration: Volumetric MRI Comparison to Parkinson’s Disease, Mild Cognitive Impairment, Alzheimer’s Disease and Elderly Healthy Controls
Dejan Jakimovski, MD, PhD
08:00 AM - 09:00 AM Abstract 9-009 - Multiplex Imaging of Immune Cells in the Multiple Sclerosis Brain
Valeria Ramaglia
08:00 AM - 09:00 AM Abstract 9-010 - Systematic Assessment of Common Error Modes in Using FIRST for MRI-based Thalamic Volumetry in People with Multiple Sclerosis
08:00 AM - 09:00 AM Abstract 9-011 - Alteration of Resting-state Functional Connectivity in Response to Structural Disruption Differs Between Well-Established Functional Networks in Multiple Sclerosis
Alexander Bartnik
08:00 AM - 09:00 AM Abstract 9-012 - Higher HDL and ApoA Apolipoproteins are Associated with Better Cerebral Perfusion in Multiple Sclerosis Patients
Dejan Jakimovski, MD, PhD
08:00 AM - 09:00 AM Abstract 9-013 - Effect of Anti-muCD52 antibody on Brain and Spinal Cord Imaging Markers of Neurodegeneration, Microglia, and Macrophage Activation in the Theiler’s Murine Encephalomyelitis Virus Model of Chronic Demyelination
Robert Zivadinov, MD, PhD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 9-014 - Longitudinal Progression of Cortical Thinning Differs Across MS Phenotypes and is Clinically Relevant: A Multicentre Study
Milagros Hidalgo de la Cruz
08:00 AM - 09:00 AM Abstract 9-016 - MRI Activity in Secondary Progressive Multiple Sclerosis
Daniella Zohar
08:00 AM - 09:00 AM Abstract 9-017 - QUANTUM – Quantitative and Standardized Imaging in Daily Clinical Routine of MS Patients
Katrin Schuh
08:00 AM - 09:00 AM Abstract 9-018 - The Gender Role in Early Multiple Sclerosis Utilizing Optical Coherence Tomography
Melody Gilroy, BS
08:00 AM - 09:00 AM Abstract 9-019 - The Role of 7T MRI to Assess Atrophy of the Subcortical Deep Gray Matter in Relapsing-remitting Multiple Sclerosis
Jonathan D. Zurawski, MD
08:00 AM - 09:00 AM Abstract 9-020 - Correlation Analysis of MRI Lesion Load and Clinical Measures in Multiple Sclerosis Cohort Using Structured Clinical Documentation Support Toolkit
Afif Hentati, MD
08:00 AM - 09:00 AM Abstract 9-021 - A Longitudinal Assessment of Fingolimod on White Brain Matter and Disease Disability in Relapsing Remitting Multiple Sclerosis
Melody Gilroy, BS
08:00 AM - 09:00 AM Abstract 9-022 - Quantitative MRI Brain Atrophy and IgG Subclass Profile: Cross Sectional Relationship In A Population of People with MS (PwMS)
Jared Srinivasan
08:00 AM - 09:00 AM Abstract 15-001 - Functional Role of Antibodies to Herpes Simplex Virus (HSV1) in Infection of the Nervous System and Autoimmunity
Marianna Spatola, MD, PhD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 15-002 - Clinical Characteristics of Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Japan
Akio Kimura, MD
08:00 AM - 09:00 AM Abstract 15-003 - Status Epilepticus Suspected Autoimmune: Antibody Frequency and Main Clinical Features
08:00 AM - 09:00 AM Abstract 15-004 - Evaluation of the Prevalence of Headache and Pain of Unknown Cause in Patients with Common Variable Immunodeficiency (CVID) Evaluate the Prevalence of Headache and Pain in Patients with Common Variable Immunodeficiency (CVID)
Lawanda Esquibel
08:00 AM - 09:00 AM Abstract 15-005 - A Retrospective, Cross-sectional Study Evaluating Plasma Neurofilament Light Levels in Autoimmune Encephalitis
Amanda L. Piquet, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 15-006 - Clinical Features, Immunotherapy, and Outcome in Patients with Cryptogenic NORSE
Takahiro Iizuka, MD
08:00 AM - 09:00 AM Abstract 15-007 - Longer Term Seizure Outcomes in a Retrospective Autoimmune Epilepsy Cohort
Sahar Noorani, MD
08:00 AM - 09:00 AM Abstract 15-008 - The Use of Rituximab in Neurological Diseases; Real World Data from a Neuroscience Centre
08:00 AM - 09:00 AM Abstract 15-009 - Real-world Experience with Ocrelizumab - A Safety Analysis
Jamie Bolling
08:00 AM - 09:00 AM Abstract 15-010 - Influence of Autoimmune Antibody Testing on Neurohospitalists’ use of Immunotherapy
Kristin M. Galetta, MD
08:00 AM - 09:00 AM Abstract 15-011 - Driving Out of Coma: Treatment of Anti-NMDA Receptor Encephalitis with Bortezomib
Maryam H. Hosseini, MD
08:00 AM - 09:00 AM Abstract 3-001 - Sex Disparities in Patients with Essential Tremor Referred for Deep Brain Stimulation
Lisa M. Deuel, MD
08:00 AM - 09:00 AM Abstract 3-002 - Vertically-Stacked Single Segment Activation (V-SSA) as a Programming Approach for Directional DBS in Globus Pallidus Internus (GPi) in Parkinson’s Disease (PD) Patients: First Clinical Case Series
Muhammad W. Anjum, MD
08:00 AM - 09:00 AM Abstract 3-003 - High-Frequency VNS Attenuates Symptom Severity and Neurodegeneration in a Rat Model of Parkinson's Disease
Ryan Verner
08:00 AM - 09:00 AM Abstract 3-004 - Natural History of Caregiver Burden After Deep Brain Stimulation for Parkinson Disease
Eric Jackowiak, MD
08:00 AM - 09:00 AM Abstract 3-005 - Unique speech change pattern in Parkinson’s disease after GPi deep brain stimulation
Shannon Y. Chiu, MD, MSc
08:00 AM - 09:00 AM Abstract 3-006 - Patient-Adjusted Deep Brain Stimulation Programming is Time-Saving in Dystonia Patients
Julien F. Bally, MD
08:00 AM - 09:00 AM Abstract 3-007 - Cultural Disparities in Deep Brain Stimulation (DBS) Decision Making in Patients with Parkinson Disease (PD)
Risako Shirane, MD, MSc
08:00 AM - 09:00 PM Abstract 3-008 - Improved Dual-Task Performance During Turning After a Single Session of Action Observation Training in Parkinson's Disease Patients
Elisabetta Sarasso
08:00 AM - 09:00 PM Abstract 3-009 - Impact of Mental Health Services and Exercise in Parkinson's Disease
08:00 AM - 09:00 PM Abstract 3-010 - Table tennis exercise for patients with Parkinson disease: a prospective pilot study
08:00 AM - 09:00 PM Abstract 3-011 - Clinically Important Change in the Fahn-Marsden Dystonia Rating Scale (FMDRS) Movement Subscale
Joan Miravite, DNP, RN, FNP-BC, FÂ鶹´«Ã½Ó³»­P, FÂ鶹´«Ã½Ó³»­, DÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 PM Abstract 3-012 - Effect of Non-contact Boxing on Non-motor Symptoms in Parkinson’s Disease
Atif Ghaffar, DO
08:00 AM - 09:00 PM Abstract 3-013 - Disparities in Access to Care and Research Participation in Advanced Parkinson's Disease: Differences between a Home Visit Study and Outpatient Clinic Population
Jori Fleisher, MD, MSCE, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 PM Abstract 3-014 - Community mobility is affected by balance and related aspects in Parkinson’s disease: preliminary results
08:00 AM - 09:00 AM Abstract 3-015 - Recruitment of a Virtual Nationwide Cohort of LRRK2 G2019S Carriers
08:00 AM - 09:00 AM Abstract 3-016 - PARK2, PINK1, and DJ1 in patients with early-onset Parkinson’s disease in four European countries.
Lukasz Milanowski, MD
08:00 AM - 09:00 AM Abstract 3-017 - The Challenge of Genetic Counselling in Early Onset Parkinsonian Disorders
Maria J. Molnar, MD, PhD
08:00 AM - 09:00 AM Abstract 12-001 - Accelerated Forgetting in Patients with Epileptic and Non-Epileptic Seizures
Rebecca L. Tom, MD, MA
08:00 AM - 09:00 AM Abstract 12-002 - Improving Cognitive Assessment of Adult Epilepsy Monitoring Unit Patients
Wendy Chen, MD
08:00 AM - 09:00 AM Abstract 12-003 - Study of Inter-relationship between Quality of Life and Cognition in People with Epilepsy - Cross Sectional Study from North Coastal Andhrapradesh
08:00 AM - 09:00 AM Abstract 12-004 - Sleep Dependent Memory Consolidation in People With Epilepsy
Fatemeh Khadjevand, MD, MPH
08:00 AM - 09:00 AM Abstract 12-005 - Polysomnographic Study of Sleep Architecture in Unselected Patients with Epilepsy: A Multicenter Study
Songtam Ngodngamtaweesuk
08:00 AM - 09:00 AM Abstract 12-006 - Is Youth Wasted on the Young? Determining Quality of Life in Older Patients with Epilepsy
Heather Heiser, MD
08:00 AM - 09:00 AM Abstract 12-007 - Psychosis and Seizures in the Veteran Population
Yarden Bornovski, MD
08:00 AM - 09:00 AM Abstract 12-008 - Systematic Literature Review on Psychiatric Comorbidities in Patients with Epilepsy
Elaine Lu, MD
08:00 AM - 09:00 AM Abstract 12-009 - Anti-Epileptic Drug Psychiatric Adverse Events in Focal Epilepsy-A Cohort Study
08:00 AM - 09:00 AM Abstract 12-010 - Are We Following Best Practices for Evaluation of Psychogenic Non-epileptic Seizures (PNES)– We Shouldn’t Need to Reinvent the Wheel
Angela Wabulya, MB ChB
08:00 AM - 09:00 AM Abstract 12-011 - Interactions of Mood Disorders and Episodic Event Frequency in Transgender Patients
08:00 AM - 09:00 AM Abstract 6-001 - Sever Hyperammonemic Encephalopathy Post Sleeve Gastrectomy
Lubna E. El Sheikh, Jr., MBBS
08:00 AM - 09:00 AM Abstract 6-002 - Cortical Laminar Necrosis Following the Rapid Correction of Hyponatremia- A Case Report
Volkan Tasdemir III, MD
08:00 AM - 09:00 AM Abstract 6-003 - Osmotic Demyelination Syndrome Without Significant Sodium Fluctuation in a Patient with NASH Cirrhosis
Terese Gullo, MD
08:00 AM - 09:00 AM Abstract 6-004 - A Rare Case of Adult-Onset Isolated Hypothalamic-Pituitary Langerhans Cell Histiocytosis Presenting with Encephalopathy due to Hypercalcemia
Nilufer Yalcin, MD
08:00 AM - 09:00 AM Abstract 6-005 - Hypercalcemia-associated PRES and Status Epilepticus
Fransisca Indraswari, MD
08:00 AM - 09:00 AM Abstract 6-006 - ImPRESsively Challenging Case of PRES
Arpan Patel, MBBS
08:00 AM - 09:00 AM Abstract 6-007 - The Overlap of Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome
Meghan Purohit, DO
08:00 AM - 09:00 AM Abstract 6-008 - Case Report Of Malignant Hypertension With Thrombotic Microangiopathy Masquerading As Thrombotic Thrombocytopenic Purpura With Neurological Features:
Sri Raghav S. Sista, MD
08:00 AM - 09:00 AM Abstract 6-009 - Rapidly Cognitive Decline Secondary to CSF Venous Fistula with Post-Operative Rebound Intracranial Hypertension and a Hyperintense Paraspinal Vein Sign Seen Retrospectively
Peter S. Tatum, DO
08:00 AM - 09:00 AM Abstract 6-010 - Spontaneous Cerebrospinal Fluid Leak Secondary to a High Auditory Stimulus: A Variant of Tullio’s Phenomenon
Roberto Alejandro Cruz, MD
08:00 AM - 09:00 AM Abstract 6-011 - Pulsatile Tinnitus Secondary to Dehiscent Right Sigmoid Sinus
08:00 AM - 09:00 AM Abstract 6-012 - Syringomyelia with Coexistent Spinal Arachnoid Cyst in a 25-year-old-male: a Case Report
Artemio A. Roxas, Jr., MD
08:00 AM - 09:00 AM Abstract 6-013 - Normal Brain with an ‘abnormal’ MRI
Nurose Karim, MD
08:00 AM - 09:00 AM Abstract 7-001 - An Optional Second Dose of Ubrogepant is Effective in Achieving 2-Hour Pain Freedom in the Acute Treatment of Migraine
Jessica Ailani, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 7-002 - Efficacy of Fremanezumab in Migraine Patients with Medication Overuse and Documented Inadequate Response to 2-4 Migraine Preventive Medication Classes: Subgroup Analysis of the Randomized, Placebo-controlled FOCUS Study
Stephen D. Silberstein, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 7-003 - Rimegepant is Effective for the Acute Treatment of Migraine in Patients Who Have Discontinued or Currently Use Triptans: Results from 3 Phase 3 Clinical Trials
Robert Croop, MD
08:00 AM - 09:00 AM Abstract 7-004 - Sustained Benefits of OnabotulinumtoxinA Treatment in Chronic Migraine: Results from a PREEMPT Pooled Analysis
Stephen D. Silberstein, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 7-005 - Effects of Galcanezumab on Acute Medication Use, Time to Response, and Total Pain Burden in Patients with Episodic Cluster Headache: Post hoc Outcomes from a Phase 3, Randomized, Double-blind, Placebo-controlled Study
Dulanji Kuruppu, MD
08:00 AM - 09:00 AM Abstract 7-006 - Long-term efficacy of erenumab in chronic migraine (CM) patients with or without acute medication overuse (AMO)
Stewart J. Tepper, MD
08:00 AM - 09:00 AM Abstract 7-007 - Eptinezumab Demonstrated Early and Sustained Reductions in HIT-6 Total and Item Scores Over Time in Patients with Chronic Migraine in the PROMISE-2 Trial
RJ Wirth, PhD
08:00 AM - 09:00 AM Abstract 7-008 - Duration of Consecutive Migraine-Free Days Experienced After Treatment with Eptinezumab in Patients with Migraine
Peter Goadsby, MD, PhD, FRS
08:00 AM - 09:00 AM Abstract 7-009 - Early Onset of Response to Fremanezumab in Migraine Patients With Moderate to Severe Depression and Documented Inadequate Response to 2-4 Classes of Migraine Preventive Treatments: Subgroup Analysis of the Randomized, Placebo-controlled FOCUS Study
Andrew M. Blumenfeld, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 7-010 - Impact of Eptinezumab Treatment on Migraine Frequency, Duration, and Severity in Patients with Migraine
Paul Winner, DO, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 7-011 - Galcanezumab in the Prevention of Chronic Migraine in Patients on Botulinum Toxin Therapy
Shivangi Singh, MD
08:00 AM - 09:00 AM Abstract 1-001 - Cyst Can't be the Case? A Unique Presentation of Multiple Tarlov Cysts
Scott Speelziek, MD
08:00 AM - 09:00 AM Abstract 1-002 - The Benefits of Neuromuscular Ultrasound Immediately After Surgery: A Case Example
Laura Danielson, MD
08:00 AM - 09:00 AM Abstract 1-003 - Muscle Thickness Measured by Ultrasound is Reduced in Neuromuscular Disorders and Correlates with Clinical and Electrophysiological findings
Alon Abraham, MD
08:00 AM - 09:00 AM Abstract 1-004 - Miller-Fisher Syndrome (MFS) with Delayed Bilateral Facial Nerve Palsy: Imaging and Electrodiagnostic Findings, Treatment and Outcome
Charles Port, MD
08:00 AM - 09:00 AM Abstract 1-005 - The Utility of Inpatient Electromyography/Nerve Conduction Studies: Quality Over Quantity Saves Quite a Quota
Derryl Miller, MD
08:00 AM - 09:00 AM Abstract 1-006 - Electromyographic Assessment of Motor Fatigue in Acute and Early Sub-Acture Stroke Patients: A Preliminary Study
Yiyun Wang
08:00 AM - 09:00 AM Abstract 1-007 - Guillain-Barre Syndrome with Dysautonomia Presenting as Posterior Reversible Leukoencephalopathy Syndrome
Emilia Raimondo, DO
08:00 AM - 09:00 AM Abstract 1-008 - Quantitative Gait Analysis in Patients with Diabetic Polyneuropathy
Kyong Jin Shin, MD
08:00 AM - 09:00 AM Abstract 1-009 - A Wearable Sensory Neuroprosthesis to Improve Gait and Balance Function in Persons with Sensory Peripheral Neuropathy – the walk2Wellness Trial
Lars Oddsson, PhD
08:00 AM - 09:00 AM Abstract 1-010 - Early Electrophysiological Prediction of Long-Term Disability in Chronic Inflammatory Demyelinating Polyneuropathy – A 14 Year Follow-Up Study
Ali Al-Zuhairy, MD, PhD
08:00 AM - 09:00 AM Abstract 1-011 - Home-Based Electrical Impedance Myography in Late-Onset Pompe Disease
Lisa Hobson-Webb, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 1-012 - Development of an Optimized Timed Up and Go (oTUG) for Measurement of Changes in Mobility Impairment in Facioscapulohumeral Muscular Dystrophy (FSHD) Clinical Trials
08:00 AM - 09:00 AM Abstract 1-013 - Validation of the Upper Extremity Reachable Work Space (RWS) as a clinical outcome assessment for FSHD Clinical Trials
Jay Han, MD
08:00 AM - 09:00 AM Abstract 1-014 - Involuntary Movements, Fasciculations, and Ion Channel Dysfunction in Multifocal Motor Neuropathy (MMN)
Christian Krarup, MD, DMSc, FRcP, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 10-001 - Cerebellar Atrophy Associated With Gait Abnormalities in Older Adult Fallers
08:00 AM - 09:00 AM Abstract 10-002 - Adult Onset Genetic Leukoencephalopathy: Practical Guide to Investigation and Results from an International Referral Centre
David S. Lynch, MBBS, PhD
08:00 AM - 09:00 AM Abstract 10-003 - Exacerbation of Alzheimer's Disease Neuropathology and Cognitive Deficits by Seizures
08:00 AM - 09:00 AM Abstract 10-004 - Magnetic Resonance Imaging Measurement of Hippocampal Volume Using Voxel-Based Morphometry Analysis in Early Alzheimer's Disease
Nobutoshi Morimoto
08:00 AM - 09:00 AM Abstract 10-005 - Impact of Cerebral Microbleeds on Cognition in Patients with Alzheimer's Disease
08:00 AM - 09:00 AM Abstract 10-006 - Quantitative Neuroimaging of Volume Loss in Persons with Alzheimer’s Dementia
Somayeh Meysami, MD
08:00 AM - 09:00 AM Abstract 10-007 - Braak Neurofibrillary Tangle Staging Prediction Using In Vivo MRI Metrics
Caroline Dallaire-Théroux, MD, PhD
08:00 AM - 09:00 AM Abstract 10-008 - [11C]MK-6884 PET Tracer for M4 Muscarinic Cholinergic Receptors in Alzheimer’s Disease: Comparison with [18F]FDG PET
Joseph C. Masdeu, MD, PhD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 10-009 - Quantitative Susceptibility Mapping MRI to Assess the Relationship Between Iron Accumulation and Hippocampal Atrophy as a Measure of the N Aspect of the A/T/N Alzheimer’s Disease Definition
Ronald J. Killiany, PhD
08:00 AM - 09:00 AM Abstract 10-010 - Free-Water Diffusion Tensor Imaging (DTI) Improves the Accuracy and Sensitivity of White Matter Analysis in Alzheimer’s Disease
Ryan R. Walsh, MD, PhD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 4-001 - FLAIR Hyperintense Vessels Do Not Correlate with MRI Perfusion Deficit
Aidan Azher, MD
08:00 AM - 09:00 AM Abstract 4-002 - Caveats to Consider for CT Angiography and Perfusion Weighted Imaging for Stroke Management in the Setting of Venoarterial Extracorporeal Membrane Oxygenation
Manuel A. Viamonte, MD
08:00 AM - 09:00 AM Abstract 4-003 - Radiologic Characteristic Of Perioperative Large Vessel Occlusions In Patients Who Underwent Transcatheter And Surgical Valve Replacement
Lucy Zhang, MD
08:00 AM - 09:00 AM Abstract 4-004 - Accuracy of Magnetic Resonance Angiography for Identifying Moderate to Severe Internal Carotid Artery Stenosis: Analysis of CREST trial
Maryum Shoukat, MD
08:00 AM - 09:00 AM Abstract 4-005 - Treatment Strategy Based on Carotid Plaque Vulnerability Identified by Simultaneous Non-contrast Angiography and IntraPlaque Hemorrhage (SNAP) Imaging
Yi Shen, MD
08:00 AM - 09:00 AM Abstract 4-006 - Collateral Strength on CT Angiography can Predict MRI Infarct Growth, but not Clinical Outcomes in Patients Treated with Mechanical Thrombectomy
Kristopher Southard, MD
08:00 AM - 09:00 AM Abstract 4-007 - Cerebral Small Vessel Disease Score and Atherosclerosis Burden: A Population-based Study in Rural Ecuador (The Atahualpa Project)
Victor J. Del Brutto, MD
08:00 AM - 09:00 AM Abstract 4-009 - Functional MRI in Ischemic Stroke Patients Treated with IV Thrombolysis and Mechanical Thrombectomy
Marco A. Gonzalez, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 4-011 - Corneal Confocal Microscopy: An Imaging Endpoint for Neuro-Immune Alterations in Acute Stroke
Adeeb M. Narangoli, MD
08:00 AM - 09:00 AM Abstract 4-012 - RAPID CT Perfusion Use in Acute Stroke; A Piece in a Puzzle
Faisal A. Ibrahim, MD
08:00 AM - 09:00 AM Abstract 4-013 - Does Brain Imaging Help in the Diagnosis And Management of Stroke in Antiphospholipid Antibody Syndrome?
Sanskriti Mishra, MD
08:00 AM - 09:00 AM Abstract 4-014 - Acute Ischemic Stroke (AIS) Due to Cerebral Lipiodol Embolization (CLE) from Diagnostic Lymphangiography
Michael Jang, MD
08:00 AM - 09:00 AM Abstract 4-015 - Diagnostic Imaging Workup of Acute Ischemic Stroke in Glioblastoma Patients
Ashley Becker, MD
08:00 AM - 09:00 AM Abstract 4-018 - Inflammatory Markers Correlate with Functional Outcomes in Large Hemispheric Infarctions
Nandini Abburi, MD
08:00 AM - 09:00 AM Abstract 4-019 - Study of Clinical, Radiological, and Electroencephalographic Features in Posterior Reversible Encephalopathy Syndrome (PRES)
Mahadevappa Mahadevappa
08:00 AM - 09:00 AM Abstract 4-020 - Varicella Zoster Vasculopathy Causing Stroke: Utility of Hi-res Vessel Wall MR Imaging in Diagnosis & Management
Elham Khalilidehkordi, MD
08:00 AM - 09:00 AM Abstract 13-001 - Unifying Variability in T2-FLAIR Mismatch Sign for Diagnosing IDH-mutant Astrocytomas and Characterizing Evolution After Treatment
Patrick Throckmorton
08:00 AM - 09:00 AM Abstract 13-002 - Brain MRI findings in Patients Treated with Chimeric Antigen Receptor T-cells (CAR-T) during Severe Neurotoxicity
Weizhe Li, MD, PhD
08:00 AM - 09:00 AM Abstract 13-003 - Examining the Impact of Isocitrate Dehydrogenase (IDH) Gene Status on the Development of Venous Thromboembolism in Glioma Patients
Jacob Mandel, MD
08:00 AM - 09:00 AM Abstract 13-004 - Temozolomide does not meaningfully reduce seizure frequency in elderly glioblastoma patients
Seth A. Climans, MD
08:00 AM - 09:00 AM Abstract 13-005 - Scores and Performance of Patient Reported Outcome Measures in Patients with High Grade Glioma at Diagnosis
Samantha P. Myers, MD
08:00 AM - 09:00 AM Abstract 13-006 - Neurotoxicity as Surrogate Marker for CAR T-cell Therapy Treatment Response
Carlen A. Yuen, MD
08:00 AM - 09:00 AM Abstract 13-007 - A New Model of Care for Patients with Central Nervous System Cancers: Final Results of a Pilot Study
Elena Pentsova, MD
08:00 AM - 09:00 AM Abstract 13-008 - Molecular Profile and Outcomes of Young Patients with Glioblastoma Multiforme. A Single Institutional Retrospective Case Series Review
Tigran Khachatryan, MD
08:00 AM - 09:00 AM Abstract 13-009 - A Pilot Study to Assess the Integration of a Unique PROQOL Tool and Early Palliative Care Intervention in the Care of High Grade Glioma Patients and their Caregivers
Akanksha Sharma, MD
08:00 AM - 09:00 AM Abstract 13-010 - Clinical Prognostic Factors of Survival in Glioblastoma Multiforme
08:00 AM - 09:00 AM Abstract 13-011 - Treatment Strategies for Glioblastoma in Older Patients: Age is Just a Number
Jacob Mandel, MD
08:00 AM - 09:00 AM Abstract 13-012 - Combined Necrosis and Brain Invasion Predict Radio-resistance and Tumor Reoccurrence in Atypical Meningioma
Monica Emili Garcia-Segura
08:00 AM - 09:00 AM Abstract 13-013 - Stroke in Cancer Patients
Marilou I. Ching, MD
08:00 AM - 09:00 AM Abstract 13-014 - Avelumab in Newly Diagnosed Glioblastoma Multiforme-the SEJ Study
Francois H. Jacques, MD
08:00 AM - 09:00 AM Abstract 5-001 - Relationship of Sleep-Related Complaint Load to Quality of Life in Epilepsy
Garik Yeganyan, MD
08:00 AM - 09:00 AM Abstract 5-002 - Comparison of Screening Instruments for Obstructive Sleep Apnea in Adults with Epilepsy
Maeve M. Pascoe Kane, MD
08:00 AM - 09:00 AM Abstract 5-003 - Screening for Obstructive Sleep Apnea in Stroke and TIA Patients using a Home Sleep Apnea Test vs. In-laboratory Polysomnography: A Randomized Controlled Trial
Mark I. Boulos, MD, FRCPC, CSCN(EEG), MSc
08:00 AM - 09:00 AM Abstract 5-004 - Low Respiratory Arousal Threshold (LRAT) in African Americans with Obstructive Sleep Apnea (OSA).
Onyedika Moghalu, MD
08:00 AM - 09:00 AM Abstract 5-005 - Comorbidity Burden of Obstructive Sleep Apnea in a Large Academic Health Center
Kevin Senanayake
08:00 AM - 09:00 AM Abstract 5-006 - The Impact of Physical Activity on Sleep Quality in Stroke-free in Adults. The Three Villages Study
Pablo R. Castillo, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 5-007 - A Pilot, Placebo-controlled Clinical Trial of Cereset Research for Insomnia
Catherine Tegeler
08:00 AM - 09:00 AM Abstract 5-008 - Brainwave Entrainment through External Sensory Stimulus : A Therapy for Insomnia
Avathvadi V. Srinivasan, MD, FÂ鶹´«Ã½Ó³»­
08:00 AM - 09:00 AM Abstract 5-009 - Efficacy and Safety of Lemborexant vs Zolpidem Extended Release and Placebo in Elderly Subjects with Insomnia: Results from SUNRISE-1
Gary Zammit
08:00 AM - 09:00 AM Abstract 5-010 - Effectiveness and Safety of Lemborexant Over 12 Months in Adults with Insomnia Disorder: Long-term Results From the Phase 3 SUNRISE-2 Study
Margaret Moline
08:00 AM - 09:00 AM Abstract 5-011 - Impact of Lemborexant Treatment on Insomnia Disease Severity and Fatigue: Results from the 12-Month Phase 3 Study SUNRISE-2
Margaret Moline
08:00 AM - 09:00 AM Abstract 5-012 - Efficacy and Safety of Lemborexant in Elderly Subjects with Insomnia Disorder: Pooled Analyses from SUNRISE-1 and SUNRISE-2
Gary Zammit
08:00 AM - 09:00 AM Abstract 5-013 - Doxepin in Children and Adolescents with Insomnia: A Single Center Experience
Yash Shah, MD, MBBS, MPH
Faculty Disclosures
Alvino Bisecco Alvino Bisecco has nothing to disclose.
Eric Klawiter, MD, FÂ鶹´«Ã½Ó³»­ Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Shadi Yaghi, MD Dr. Yaghi has nothing to disclose.
Kathryn S. Nevel, MD Dr. Nevel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals. Dr. Nevel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Nevel has received publishing royalties from a publication relating to health care. Dr. Nevel has received personal compensation in the range of $500-$4,999 for serving as a Interviewer with Continuum Audio.
Marianna Spatola, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation. The institution of Dr. Spatola has received research support from European Research Coucil.
Josep O. Dalmau, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Â鶹´«Ã½Ó³»­ Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' Â鶹´«Ã½Ó³»­ Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical Â鶹´«Ã½Ó³»­. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research Â鶹´«Ã½Ó³»­ Social Awareness and Training In Neurosciences.
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kallyope. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seaport Therapeutics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddy's. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
James A. Mastrianni, MD, PhD Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Mastrianni has received research support from Brain Research Foundation.
Renato P. Munhoz, MD, PhD Dr. Munhoz has nothing to disclose.
Torrey B. Birch, MD, FÂ鶹´«Ã½Ó³»­ Dr. Birch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon Biosciences.
Sepideh Mokhtari, MD Dr. Mokhtari has nothing to disclose.
Kourosh Rezania, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rezania has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea. Dr. Rezania has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
E. Ray Dorsey, MD, MBA Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seelos Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eden McCallum, LLP. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioSensics. Dr. Dorsey has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Mediflix. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevance. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kairos Cinema, LLC. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medrhythms. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ANA. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HMP Â鶹´«Ã½Ó³»­, LLP. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ADIVO Associates France. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for University of Toronto. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philadelphia Neurological Society. Dr. Dorsey has stock in Included Health. Dr. Dorsey has stock in Mediflix. Dr. Dorsey has stock in SemCap. Dr. Dorsey has stock in Synapticure. The institution of Dr. Dorsey has received research support from NIH/NINDS. The institution of Dr. Dorsey has received research support from Burroughs Wellcome . The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Fox Insight. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Emerald. The institution of Dr. Dorsey has received research support from B. Thomas Golisano Foundation. The institution of Dr. Dorsey has received research support from Emerald Innovations, Inc.. The institution of Dr. Dorsey has received research support from Photopharmics Inc.. The institution of Dr. Dorsey has received research support from Averitas Pharma Inc.. The institution of Dr. Dorsey has received research support from DOD/Army Medical Research Acquisition Activity. The institution of Dr. Dorsey has received research support from NIH/NINDS.
Nimish A. Mohile, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Mohile has received research support from Novocure.
Gretchen L. Birbeck, MD, MPH, DTMH, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Thomas J. Kelly, MD No disclosure on file
Afif Hentati, MD Dr. Hentati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hentati has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Hentati has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for INSPE.
Lisa M. Deuel, MD Dr. Deuel has nothing to disclose.
Massimo Filippi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Mario F. Mendez, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Â鶹´«Ã½Ó³»­ Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Sarah Song, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­.
No disclosure on file
Murali Ramanathan, PhD The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Alfonso Fasano, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Jessica Ailani, MD, FÂ鶹´«Ã½Ó³»­ Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Paul Winner, DO, FÂ鶹´«Ã½Ó³»­ Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for lilly. The institution of Dr. Winner has received research support from Amgen. The institution of Dr. Winner has received research support from Allergan. The institution of Dr. Winner has received research support from Lundbeck . The institution of Dr. Winner has received research support from Novartis. The institution of Dr. Winner has received research support from Lilly. The institution of Dr. Winner has received research support from Teva. The institution of Dr. Winner has received research support from Supernus. The institution of Dr. Winner has received research support from Biogen. The institution of Dr. Winner has received research support from Avinar. The institution of Dr. Winner has received research support from SAMUS.
Roy Alcalay, MD Dr. Alcalay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme/Sanofi. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gain Therapeutics. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vanqua Bio. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Capsida. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Alcalay has received research support from Michael J. Fox Foundation. The institution of Dr. Alcalay has received research support from Parkinson's Foundation. The institution of Dr. Alcalay has received research support from Silverstein Foundation. Dr. Alcalay has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Parkinson's Foundation.
Peggy Auinger Ms. Auinger has nothing to disclose.
Joshua P. Klein, MD, PhD, FANA, FÂ鶹´«Ã½Ó³»­ Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oakstone Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer Publishers. Dr. Klein has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for various law firms. Dr. Klein has received publishing royalties from a publication relating to health care.
Kara Stavros, MD, FÂ鶹´«Ã½Ó³»­ Dr. Stavros has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare LLC. Dr. Stavros has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Rhode Island Medical Society.
Harini Sarva, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuroderm. Dr. Sarva has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Insightec. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Sun Pharma. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB. The institution of Dr. Sarva has received research support from MeiraGTX. The institution of Dr. Sarva has received research support from Biohaven. The institution of Dr. Sarva has received research support from Vima.
Robert Stern, PhD Robert Stern, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Robert Stern, PhD has received research support from Eisai. The institution of Robert Stern, PhD has received research support from Lilly. The institution of Robert Stern, PhD has received research support from ATRI/NIA. Robert Stern, PhD has received publishing royalties from a publication relating to health care. Robert Stern, PhD has a non-compensated relationship as a Member with NFLPA Mackey-White Committee that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Yasushi Kisanuki, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kisanuki has nothing to disclose.
Margaret Moline Margaret Moline has received personal compensation for serving as an employee of EISAI, INC.. Margaret Moline has received intellectual property interests from a discovery or technology relating to health care. Margaret Moline has received personal compensation in the range of $0-$499 for serving as a review, loan repayment program with NIH.
Larisa Yedigarova Larisa Yedigarova has received personal compensation for serving as an employee of AbbVie. Larisa Yedigarova has received stock or an ownership interest from AbbVie.
Xuling Lin, MD The institution of Dr. Lin has received research support from National Health Innovation Center.
Xiaoping Ning Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical . Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical.
M. M. Paz Soldan, MD, PhD Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Shamik Bhattacharyya, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Starane A. Shepherd, MD Dr. Shepherd has nothing to disclose.
Richard S. Nicholas, FRCP Dr. Nicholas has nothing to disclose.
Niels Bergsland Prof. Bergsland has nothing to disclose.
Charles H. Tegeler, MD Dr. Tegeler has nothing to disclose.
Lisa Hobson-Webb, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Therapeutics. Dr. Hobson-Webb has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . The institution of Dr. Hobson-Webb has received research support from Abcuro. The institution of Dr. Hobson-Webb has received research support from Avidity. Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³»­al Talk - not speaker bureau with Takeda. Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³»­al Talk - not speaker bureau with CSL Behring.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Yuichi Hayashi Yuichi Hayashi has nothing to disclose.
Anat Mirelman Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. The institution of Anat Mirelman has received research support from Department of Defense. The institution of Anat Mirelman has received research support from MJFF. The institution of Anat Mirelman has received research support from JPND. The institution of Anat Mirelman has received research support from EU-Horizon 2020.
Hannah Breit, MD Dr. Breit has nothing to disclose.
Jonathan R. Galli, MD Dr. Galli has nothing to disclose.
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Joan Miravite, DNP, RN, FNP-BC, FÂ鶹´«Ã½Ó³»­P, FÂ鶹´«Ã½Ó³»­, DÂ鶹´«Ã½Ó³»­ Dr. Miravite has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Miravite has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Miravite has a non-compensated relationship as a Board Member with Association of Movement Disorder Advanced Practice Providers that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Florence Pasquier, MD Dr. Pasquier has nothing to disclose.
Jacqueline French, MD, FÂ鶹´«Ã½Ó³»­ Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Hussam A. Yacoub, DO Dr. Yacoub has nothing to disclose.
Lucy Zhang, MD Dr. Zhang has nothing to disclose.
H. C. Diener, MD, FÂ鶹´«Ã½Ó³»­ Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council.
Robert Zivadinov, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Carlos Perdomo No disclosure on file
Shlomit Yust-Katz, MD Dr. Yust-Katz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for pfizer. Dr. Yust-Katz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Organon. Dr. Yust-Katz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. The institution of Dr. Yust-Katz has received research support from MERK.
Katrin Schuh Katrin Schuh has received personal compensation for serving as an employee of Novartis Pharma GmbH.
John F. De Groot, MD An immediate family member of Dr. De Groot has received personal compensation for serving as an employee of Ziopharm Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Deciphera Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for FivePrime Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Carthera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kadmon. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Biomedical Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Taiho Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kairos Venture Investments. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Syneos Health. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Monteris. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Agios. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mundipharma Research. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GenomiCare. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Del Mar Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tocagen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioasis Technologies, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ResTORbio, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation Medicine, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novogen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Deciphera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insys Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lily. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella Clinical. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karyopharm Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiyatec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanquish Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orsenix, Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Global Services, LLC. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBL Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines, Inc.. An immediate family member of Dr. De Groot has received stock or an ownership interest from Ziopharm Oncology. An immediate family member of Dr. De Groot has received stock or an ownership interest from Gilead. The institution of Dr. De Groot has received research support from Carthera. The institution of Dr. De Groot has received research support from HaiHe Pharma. The institution of Dr. De Groot has received research support from Taiho Pharma.
Tirisham Gyang, MD Dr. Gyang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono.
Elisabetta Pagani Elisabetta Pagani has nothing to disclose.
Ryan R. Walsh, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Walsh has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Walsh has stock in Praxis Precision Medicines.
Vivian E. Drory, MD Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Prof. Drory has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison Pharma. The institution of Prof. Drory has received research support from Neurosense Therapeutics. The institution of Prof. Drory has received research support from AB Science. The institution of Prof. Drory has received research support from Biogen. The institution of Prof. Drory has received research support from Neuralight.
May A. Kim-Tenser, MD, MHA, FAHA Dr. Kim-Tenser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi.
Ashfaq Shuaib, MD Dr. Shuaib has nothing to disclose.
Robert G. Holloway, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Holloway has nothing to disclose.
Arman Sabet, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sabet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Sabet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Sabet has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for BOD Australia. Dr. Sabet has stock in CSL.
Vikas Kotagal, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.
Francois H. Jacques, MD No disclosure on file
Scheherazade Le, MD Dr. Le has nothing to disclose.
Naresh Mullaguri, MD Dr. Mullaguri has nothing to disclose.
Andres M. Kanner, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Kanner has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Foundation of America. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving as a Lecture at International meeting with Eisai.
Oscar H. Del Brutto, MD, FÂ鶹´«Ã½Ó³»­ Dr. Del Brutto has received research support from Universidad Espiritu Santo - Ecuador.
Kimford J. Meador, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
Avathvadi V. Srinivasan, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Saadat Kamran, MD No disclosure on file
Ken Uchino, MD Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Ali Saad, MD, FÂ鶹´«Ã½Ó³»­ Dr. Saad has nothing to disclose.
John Pula, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pula has nothing to disclose.
Deric M. Park, MD No disclosure on file
Joel M. Trugman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Naveed Akhtar, MD, FÂ鶹´«Ã½Ó³»­ Dr. Akhtar has nothing to disclose.
Deborah I. Friedman, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsone. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Friedman has a non-compensated relationship as a President-elect, Board of Directors with Southern Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Andres M. Lozano, MD Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Neuromodulation.
Anat Achiron, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Achiron has nothing to disclose.
Takahiro Iizuka, MD The institution of Dr. Iizuka has received research support from EUROIMMUN Japan Co., Ltd.
Pablo R. Castillo, MD, FÂ鶹´«Ã½Ó³»­ Dr. Castillo has nothing to disclose.
Jesse B. Mez, MD The institution of Dr. Mez has received research support from NIH, DOD.
Akash J. Patel No disclosure on file
Natalia Murinova, MD, FÂ鶹´«Ã½Ó³»­ Dr. Murinova has nothing to disclose.
Ivan Da Silva, MD Dr. Da Silva has nothing to disclose.
James F. Sumowski Mr. Sumowski has nothing to disclose.
Teddy S. Youn, MD Dr. Youn has nothing to disclose.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Stacey Clardy, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/Â鶹´«Ã½Ó³»­ Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³»­ Summer Meeting CoDirector Travel and Lodging with Â鶹´«Ã½Ó³»­. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed.
Takayoshi Shimohata, MD, FÂ鶹´«Ã½Ó³»­ Dr. Shimohata has nothing to disclose.
Doris Kung, DO, FÂ鶹´«Ã½Ó³»­ Dr. Kung has received personal compensation for serving as an employee of Aquifer. The institution of Dr. Kung has received research support from RxFunction. Dr. Kung has received publishing royalties from a publication relating to health care. Dr. Kung has received personal compensation in the range of $0-$499 for serving as a Workgroup member with NBME. Dr. Kung has received personal compensation in the range of $500-$4,999 for serving as a Editor with Aquifer.
Vladimir Coric Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Paolo Preziosa Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Jori Fleisher, MD, MSCE, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. The institution of Dr. Fleisher has received research support from NIA/NINDS. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with Â鶹´«Ã½Ó³»­ Brain & Life Magazine that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Verena Ramirez Campos, MD Dr. Ramirez Campos has received personal compensation for serving as an employee of teva.
Tom Fuchs Mr. Fuchs has nothing to disclose.
Sam S. Handshoe Dr. Handshoe has nothing to disclose.
Patricia Pozo-Rosich, MD, PhD Dr. Pozo-Rosich has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pozo-Rosich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Organon. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy's. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sociedad Española Neurologia.
Emilia Raimondo, DO Dr. Raimondo has nothing to disclose.
Cynthia Bodkin, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bodkin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Bodkin has received research support from Massachusetts General Hospital. The institution of Dr. Bodkin has received research support from Alector LL. The institution of Dr. Bodkin has received research support from Atlantic research group. The institution of Dr. Bodkin has received research support from Amicus Therapeutics. The institution of Dr. Bodkin has received research support from Alexion. The institution of Dr. Bodkin has received research support from Anelixis. The institution of Dr. Bodkin has received research support from Medicinova INC. The institution of Dr. Bodkin has received research support from Ra Pharmaceuticals Inc.
Richard B. Lipton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Alyx B. Porter, MD, FÂ鶹´«Ã½Ó³»­ Dr. Porter has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
John E. Greenlee, MD, FÂ鶹´«Ã½Ó³»­ Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
William J. Powers, MD, FÂ鶹´«Ã½Ó³»­ Dr. Powers has a non-compensated relationship as a Chair of the Writing Group for Acute Ischemic Stroke Guidelines with American Heart Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Michael G. Dwyer III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
David G. Munoz, MD No disclosure on file
Rachel J. Saunders-Pullman, MD The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Sven Schippling No disclosure on file
Paola Valsasina Paola Valsasina has nothing to disclose.
Nir Giladi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University.
Ronald J. Killiany, PhD Dr. Killiany has nothing to disclose.
Lauren Koffman, DO, MS Dr. Koffman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Law Firm. Dr. Koffman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Walters Kluwer.
Aaron M. Carlson, MD Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
Michael Alosco, PhD The institution of Michael Alosco, PhD has received research support from NIH. The institution of Michael Alosco, PhD has received research support from Life Molecular Imaging Inc.
Somayeh Meysami, MD Dr. Meysami has nothing to disclose.
Bhageeradh Mulpur, MD Dr. Mulpur has nothing to disclose.
Angela Wabulya, MB ChB Dr. Wabulya has nothing to disclose.
Louise D. McCullough, MD, PhD The institution of Dr. McCullough has received research support from NIH. The institution of Dr. McCullough has received research support from American Heart Association.
Michael C. Smith, MD, FÂ鶹´«Ã½Ó³»­ Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Lifesciences. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SK Lifesciences .
Jeremy S. Chataway, MD Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NerveGen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
David S. Lynch, MBBS, PhD Dr. Lynch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil Neuroscience. Dr. Lynch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Lynch has received research support from Ionis.
Elliot M. Frohman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Kan Ding, MD The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Kinga Szigeti, MD, PhD No disclosure on file
Thomas J. Guttuso, MD Dr. Guttuso has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Guttuso has received stock or an ownership interest from e3 Pharmaceuticals.
Sanskriti Mishra, MD No disclosure on file
Steven Vernino, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
Divyanshu Dubey, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
David G. Lichter, FRACP, MBChB, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Rohit Das, MD, FÂ鶹´«Ã½Ó³»­ Dr. Das has received personal compensation for serving as an employee of Oregon Health Science University. Dr. Das has received personal compensation in the range of $10,000-$49,999 for serving as a Physician Advisor with Concentra .
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Irene Cortese, MD Dr. Cortese has stock in Keires, AG. Dr. Cortese has stock in Nouscom, AG. Dr. Cortese has stock in PDC*line Pharma.
David Pitt, MD Dr. Pitt has nothing to disclose.
Valeria Ramaglia No disclosure on file
Rohit Bakshi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
Nancy R. Foldvary-Schaefer, DO, FÂ鶹´«Ã½Ó³»­ Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Jeffrey L. Bennett, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
James C. Grotta, MD, FÂ鶹´«Ã½Ó³»­ Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Ralph H. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Alexandre Prat, MD The institution of Dr. Prat has received research support from CIHR and MSSC.
Laura A. Cinski, MD No disclosure on file
Rebecca O'Dwyer, MD Dr. O'Dwyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. O'Dwyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Sciences.
Andrea Tettamanti No disclosure on file
Henry Houlden No disclosure on file
Praveen Hariharan, MD Dr. Hariharan has nothing to disclose.
David J. Gladstone, MD No disclosure on file
David W. Dodick, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Â鶹´«Ã½Ó³»­ Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Susan B. Bressman, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Melissa M. Cortez, DO The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Jacob Mandel, MD Dr. Mandel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SERVIER PHARMACEUTICALS LLC (US). Dr. Mandel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BAYER HEALTHCARE PHARMACEUTICALS (US.
Nobuaki Yoshikura, MD, PhD Dr. Yoshikura has nothing to disclose.
Hossam A. Shaltout, PhD Dr. Shaltout has nothing to disclose.
Joshua Santucci, MD Dr. Santucci has nothing to disclose.
Akio Kimura, MD Dr. Kimura has nothing to disclose.
Maciej M. Mrugala, MD, PhD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Bradley V. Vaughn, MD, FÂ鶹´«Ã½Ó³»­ Dr. Vaughn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Â鶹´«Ã½Ó³»­ Resources. Dr. Vaughn has received publishing royalties from a publication relating to health care. Dr. Vaughn has received publishing royalties from a publication relating to health care. Dr. Vaughn has a non-compensated relationship as a speaker/course director with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Esther Cubo Delgado, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Pasiri Sithinamsuwan, MD No disclosure on file
Kavita Nair, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Irene L. Katzan, MD Dr. Katzan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . The institution of Dr. Katzan has received research support from TEVA Pharmaceuticals.
Kelly D. Foote, MD Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
Jerome J. Graber, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Graber has received personal compensation for serving as an employee of Binaytara Foundation. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Â鶹´«Ã½Ó³»­. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dickie McCamey Attorneys at Law. Dr. Graber has a non-compensated relationship as a Editorial Board member with Neuro-Oncology: Practice, published by Oxford that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Journal of Pain and Symptom Management that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors and Certification Exam Committee Member with United Council of Neurological Subspecialties that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Graber has a non-compensated relationship as a Question of the Day 'app' committee and NeuroSAE and Continuum with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Practical Neurology (BMC) that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Marco A. Gonzalez, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gonzalez Castellon has nothing to disclose.
Matthew R. Burns, MD, PhD The institution of Dr. Burns has received research support from NIH. The institution of Dr. Burns has received research support from Mcknight Brain Institute.
Stefan Sillau Stefan Sillau has nothing to disclose.
Derek W. Stitt, MD Dr. Stitt has nothing to disclose.
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
David B. Kudrow, MD Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Adolfo Ramirez Zamora, MD Dr. Ramirez Zamora has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel therapeutics. Dr. Ramirez Zamora has received personal compensation in the range of $0-$499 for serving as a Consultant for NeuroPacs. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota Inc. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maplight. Dr. Ramirez Zamora has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of Dr. Ramirez Zamora has received research support from Parkinsons Foundation.
Warren P. Mason, MD, FÂ鶹´«Ã½Ó³»­ Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Ingelheim. Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Therapeutics.
Victor J. Del Brutto, MD The institution of Dr. Del Brutto has received research support from Florida Health Department. The institution of Dr. Del Brutto has received research support from american heart association.
Elisabetta Sarasso Elisabetta Sarasso has nothing to disclose.
Joseph C. Masdeu, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Jan L. Brandes, MD Dr. Brandes has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Brandes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Brandes has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly. Dr. Brandes has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Amgen. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Brandes has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Lewis Thomason. Dr. Brandes has received research support from Amgen. Dr. Brandes has received research support from Teva. Dr. Brandes has received research support from Allergan. Dr. Brandes has received research support from Biohaven. Dr. Brandes has a non-compensated relationship as a Board Member with National Headache Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Gregory A. Worrell, MD Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care.
Dinesh Kumar Dinesh Kumar has received personal compensation for serving as an employee of Eisai Inc.
Leonardo Almeida No disclosure on file
Kyong Jin Shin, MD No disclosure on file
Prateeka Koul, MD Dr. Koul has nothing to disclose.
John W. Rose, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Deborah H. Hall, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Stephen D. Silberstein, MD, FÂ鶹´«Ã½Ó³»­ Dr. Silberstein has received publishing royalties from a publication relating to health care.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Sayona John, MD, FÂ鶹´«Ã½Ó³»­ Dr. John has nothing to disclose.
Joshua M. Cohen, MD No disclosure on file
Catherine Tegeler Ms. Tegeler has nothing to disclose.
Dejan Jakimovski, MD, PhD Dr. Jakimovski has nothing to disclose.
Suyog U. Pol, PhD Dr. Pol has nothing to disclose.
Vanessa K. Hinson, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Hinson has received research support from Biogen. The institution of Dr. Hinson has received research support from Scion Neurostim. The institution of Dr. Hinson has received research support from PPD Development/Takeda Development. The institution of Dr. Hinson has received research support from Parexel Biopharma. The institution of Dr. Hinson has received research support from Impax Laboratories.
Harry H. Hill, MD No disclosure on file
Inbal Maidan, PhD Dr. Maidan has nothing to disclose.
Lindsay J. Howard Ms. Howard has nothing to disclose.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Brian Grosberg, MD Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma pharmaceuticals. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theranica . Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Grosberg has stock in Theranica. The institution of Dr. Grosberg has received research support from Theranica. The institution of Dr. Grosberg has received research support from Amgen. The institution of Dr. Grosberg has received research support from Abbvie. The institution of Dr. Grosberg has received research support from Eli Lilly. The institution of Dr. Grosberg has received research support from Teva. The institution of Dr. Grosberg has received research support from Neurolief. Dr. Grosberg has received publishing royalties from a publication relating to health care.
Timothy L. Vollmer, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Marilou I. Ching, MD Dr. Ching has nothing to disclose.
Ryan Hays, MD, MBA, FAES, FÂ鶹´«Ã½Ó³»­ Dr. Hays has nothing to disclose.
Alexandra L. Czap, MD The institution of Dr. Czap has received research support from SVIN. The institution of Dr. Czap has received research support from Â鶹´«Ã½Ó³»­.
J G. Cairncross, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Steven Levine, MD, FAHA Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
David Hojnacki, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Gary Zammit Gary Zammit has received personal compensation for serving as an employee of Clinilabs, Inc.. Gary Zammit has received stock or an ownership interest from Clinilabs, Inc. Gary Zammit has received stock or an ownership interest from Sleep Disorders Institute. Gary Zammit has received stock or an ownership interest from Home Sleep and Respiratory Care.
James Martinez No disclosure on file
Erik K. St. Louis, MD The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Raghav Govindarajan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Hadar Kolb Hadar Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Hadar Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Hadar Kolb has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MAPI pharma. Hadar Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Scientific. Hadar Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marck. The institution of Hadar Kolb has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI pharma. Hadar Kolb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison pharma. Hadar Kolb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marck.
Daniel Reich, MD, PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Shahamat Tauhid, MD Dr. Tauhid has nothing to disclose.
James R. Perry, MD, FRCP(C), FÂ鶹´«Ã½Ó³»­ The institution of Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Enveric Biosciences . The institution of Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Canadian Brain Tumour Consortium. Dr. Perry has stock in Synaptive Medical.
Jonathan D. Zurawski, MD The institution of Dr. Zurawski has received research support from The Race to Erase MS Foundation. The institution of Dr. Zurawski has received research support from Novartis Pharmaceuticals. The institution of Dr. Zurawski has received research support from I-Mab Biopharma . The institution of Dr. Zurawski has received research support from Elizabeth A. Kremer MS Research Foundation. The institution of Dr. Zurawski has received research support from Novartis.
Matthew R. Mallory No disclosure on file
Miriam R. Rafferty, PhD, PT No disclosure on file
Andrew M. Blumenfeld, MD, FÂ鶹´«Ã½Ó³»­ Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Muhammad S. Hussain, MD Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiger Medical.
Priya Kishnani, MD Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maze Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for JCR Pharmaceutical. Priya Kishnani, MD has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Asklepios Biopharmaceutical Inc. (AskBio). Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Baebies, Inc.. The institution of Priya Kishnani, MD has received research support from Sanofi/Genzyme. Priya Kishnani, MD has received research support from Amicus Therapeutics. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care.
Michael B. Tennison, MD No disclosure on file
Cyrus A. Raji, MD, PhD Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainreader ApS. Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Health . Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neurevolution Medicine.
Russell Rosenberg Mr. Rosenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Mr. Rosenberg has received research support from Neurotrials Research.
Hai Chen, MD, PhD Dr. Chen has nothing to disclose.
Govind Nair No disclosure on file
Michael S. Okun, MD, FÂ鶹´«Ã½Ó³»­ Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Teresa Frohman, PA No disclosure on file
Belen Pascual, PhD The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Fernando Cubillos Mr. Cubillos has nothing to disclose.
Paolo Zanotti Fregonara Paolo Zanotti Fregonara has nothing to disclose.
Roger Cady, MD Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Amanda L. Piquet, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Mariel Deutsch, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Jesper Hagemeier No disclosure on file
Fatemeh Khadjevand, MD, MPH Dr. Khadjevand has nothing to disclose.
Alexander Bartnik No disclosure on file
Maria J. Molnar, MD, PhD Dr. Molnar has nothing to disclose.
Maria Barcikowska, MD No disclosure on file
Johannes Jakobsen, MD, DMSci The institution of Dr. Jakobsen has received research support from TAKEDA. Dr. Jakobsen has received publishing royalties from a publication relating to health care. Dr. Jakobsen has received personal compensation in the range of $5,000-$9,999 for serving as a Advisor with Danish Medicine Counsil.
Delia M. Talos, MD No disclosure on file
Marijean Buhse Marijean Buhse has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Ajaz Sheikh, MD Dr. Sheikh has nothing to disclose.
Laura Danielson, MD Dr. Danielson has nothing to disclose.
Emily Anderson No disclosure on file
David Zhang, PhD No disclosure on file
Risako Shirane, MD, MSc Dr. Shirane has nothing to disclose.
Shawna M. Cutting, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Cutting has received research support from Genentech.
H. E. Hinson, MD, MCR, FÂ鶹´«Ã½Ó³»­ Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Murat Kurtuncu, MD Dr. Kurtuncu has nothing to disclose.
Brian J. Murray, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care.
Federica Esposito Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care.
Elena Pentsova, MD The institution of Dr. Pentsova has received research support from YmAbs Therapeutics, Inc.
Aidan Azher, MD Dr. Azher has nothing to disclose.
Tuncay Gunduz, MD The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
Eiji Kitamura Eiji Kitamura has nothing to disclose.
James McGinley James McGinley has received personal compensation for serving as an employee of Vector Psychometric Group, LLC. An immediate family member of James McGinley has received personal compensation for serving as an employee of UPMC Children's Community Pediatrics. James McGinley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for McGinley Statistical Consulting, LLC. James McGinley has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Cephalalgia (journal). James McGinley has stock in various companies. The institution of James McGinley has received research support from National Headache Foundation.
Demetrius M. Maraganore, MD, FÂ鶹´«Ã½Ó³»­ Dr. Maraganore has nothing to disclose.
Kazutoshi Nishiyama, MD, PhD Kazutoshi Nishiyama, MD, PhD has nothing to disclose.
Diego Cadavid, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
Christian Krarup, MD, DMSc, FRcP, FÂ鶹´«Ã½Ó³»­ Dr. Krarup has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Shire/Takeda. Dr. Krarup has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shire/Takeda. Dr. Krarup has received publishing royalties from a publication relating to health care.
Hamada H. Altalib, DO The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
Evanthia Bernitsas, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Artemio A. Roxas, Jr., MD Dr. Roxas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Philippines.
Sarah Barnard Sarah Barnard has nothing to disclose.
Joy E. Burke, MD No disclosure on file
Chinazom U. Ibegbu, MD Dr. Ibegbu has nothing to disclose.
Monica Scarsella, MD Dr. Scarsella has nothing to disclose.
Meghan Purohit, DO Dr. Purohit has nothing to disclose.
Gaurav Singh, MBBS No disclosure on file
Samantha P. Myers, MD Ms. Myers has nothing to disclose.
Suneil Kalia Suneil Kalia has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbott. Suneil Kalia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston. Suneil Kalia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Suneil Kalia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novonordisk. The institution of Suneil Kalia has received research support from CIHR. Suneil Kalia has received research support from MJFF. The institution of Suneil Kalia has received research support from Parkinson Canada.
Carrie R. Houts Carrie R. Houts has received personal compensation for serving as an employee of Vector Psychometric Group, LLC.
Victoria Sing-Curry No disclosure on file
Daniella Zohar No disclosure on file
Simon Duchesne, PhD Dr. Duchesne has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Qynapse SAS. Dr. Duchesne has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Group. Dr. Duchesne has received stock or an ownership interest from Qynapse SAS. Dr. Duchesne has received intellectual property interests from a discovery or technology relating to health care.
Tao Xie, MD Dr. Xie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS/Caremark. Dr. Xie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharmaceutical Ltd. Dr. Xie has received research support from NIH.
Ruth Schneider, MD, FÂ鶹´«Ã½Ó³»­ Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Escape Bio. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Acadia Pharmaceuticals. The institution of Dr. Schneider has received research support from CHDI. The institution of Dr. Schneider has received research support from Biohaven Pharmaceuticals. The institution of Dr. Schneider has received research support from Parkinson Study Group. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from Bial. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Telemedicine Evaluator with Parkinson's Foundation.
Muhammad W. Anjum, MD Dr. Anjum has nothing to disclose.
Zygmunt Jamrozik, MDPHD No disclosure on file
Messoud Ashina, MD, PhD Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GlaxoSmithKline. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Incyte. The institution of Dr. Ashina has received research support from The Lundbeck Foundation. The institution of Dr. Ashina has received research support from Novo Nordisk Foundation . The institution of Dr. Ashina has received research support from Danish National Research Foundation . Dr. Ashina has received publishing royalties from a publication relating to health care.
Faisal A. Ibrahim, MD Dr. Ibrahim has nothing to disclose.
Michael A. Lane, MD Dr. Lane has nothing to disclose.
Sunfa Cheng Sunfa Cheng has received personal compensation for serving as an employee of Amgen. Sunfa Cheng has received stock or an ownership interest from Amgen.
Andrew Russo Andrew Russo has nothing to disclose.
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Peter Balicza No disclosure on file
Chiara Zecca, MD Prof. Zecca has nothing to disclose.
Milagros Hidalgo de la Cruz Milagros Hidalgo de la Cruz has nothing to disclose.
Ali Al-Zuhairy, MD, PhD Dr. Al-Zuhairy has nothing to disclose.
Christina Palmese Christina Palmese has nothing to disclose.
Natalya Machado No disclosure on file
Barbara C. Jobst, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC.
Benjamin D. Tolchin, MD, MS, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Tolchin has received research support from C.G. Swebilius Trust.
Zbigniew K. Wszolek, MD, FÂ鶹´«Ã½Ó³»­ Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Claudio Gobbi, MD Dr. Gobbi has nothing to disclose.
Francesca Sangalli No disclosure on file
Neel Madan No disclosure on file
Matthew McCaskill, DO Dr. McCaskill has nothing to disclose.
Allison Fryman Allison Fryman has nothing to disclose.
Peter S. Tatum, DO No disclosure on file
Yiyun Wang No disclosure on file
Maurizio Bergamino No disclosure on file
Katarzyna Smilowska, MD No disclosure on file
Ahmed Abbas, MD Dr. Abbas has nothing to disclose.
Maya N. Hatch, PhD Maya Hatch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioniks. Maya Hatch has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. The institution of Maya Hatch has received research support from Fulcrum Therapeutics.
Anthony S. Basile, PhD Dr. Basile has received personal compensation for serving as an employee of Merck Research Labs. Dr. Basile has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Above and Beyond Research. Dr. Basile has received stock or an ownership interest from Merck Research Labs. Dr. Basile has received intellectual property interests from a discovery or technology relating to health care.
Seth A. Climans, MD Dr. Climans has nothing to disclose.
Edina Komlodi-Pasztor, MD, PhD Dr. Komlodi-Pasztor has nothing to disclose.
Takashi Tsuboi, PhD No disclosure on file
Hong K. Song, MD No disclosure on file
Andrea Gardoni No disclosure on file
J S. Andrews J Scott Andrews has received personal compensation for serving as an employee of Eli Lilly & Company. J Scott Andrews has received stock or an ownership interest from Eli Lilly & Company.
Jian Wu, PhD Dr. Wu has nothing to disclose.
Nicole A. Lessard, RN Ms. Yarab has nothing to disclose.
Courtney Knapp No disclosure on file
Garik Yeganyan, MD Dr. Yeganyan has nothing to disclose.
Pawan K. Singh, MD Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier Pharmaceuticals.
Victor Lin, MD No disclosure on file
Nevin A. John, MBBS Dr. John has nothing to disclose.
Gianna Carla Riccitelli No disclosure on file
Michael Youssef, MD Dr. Youssef has nothing to disclose.
Maryam H. Hosseini, MD Dr. Hosseini has nothing to disclose.
Adelene Jann, MD Dr. Jann has nothing to disclose.
Katarzyna Slota, MD No disclosure on file
Adeeb M. Narangoli, MD Mr. Narangoli has nothing to disclose.
Jennifer N. Serventi, PA Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
Drew S. Kern, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Kern has received research support from Boston Scientific. The institution of Dr. Kern has received research support from AbbVie Pharmaceticals. Dr. Kern has received research support from Medtronic.
Anthony Reder, MD Dr. Reder has nothing to disclose.
Jay Han, MD No disclosure on file
Carla E. Santiago-Martinez Ms. Santiago-Martinez has nothing to disclose.
Tiffani S. Franada, DO, FÂ鶹´«Ã½Ó³»­ Dr. Franada has nothing to disclose.
Wendy Chen, MD Dr. Chen has nothing to disclose.
RJ Wirth, PhD RJ Wirth has received personal compensation for serving as an employee of Vector Psychometric Group, LLC.
Victoria D. Liu, MD No disclosure on file
Peter Bailey, MD No disclosure on file
Michael Jang, MD No disclosure on file
Paul Cannon No disclosure on file
Caroline Dallaire-Théroux, MD, PhD Dr. Dallaire-Théroux has received research support from Canadian Institutes of Health Research (CIHR).
Paolo Muraro Paolo Muraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Paolo Muraro has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Pinsent Masons LLP. Paolo Muraro has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Taylor Wessing LLP. Paolo Muraro has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bugge Valentin. Paolo Muraro has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Lambert Hornby LLP. The institution of Paolo Muraro has received research support from NIHR-EME. The institution of Paolo Muraro has received research support from Benaroya Research Institute.
Deborah M. Green-LaRoche, MD The institution of Dr. Green-LaRoche has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Clinical Trials. Dr. Green-LaRoche has received publishing royalties from a publication relating to health care.
Daniel D. Mikol, MD, PhD Dr. Mikol has received personal compensation for serving as an employee of NervGen. Dr. Mikol has received personal compensation for serving as an employee of Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for NervGen. Dr. Mikol has stock in NervGen. Dr. Mikol has stock in Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with NervGen.
Jaroslaw Slawek, MD No disclosure on file
Gayane R. Melikyan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Melikyan has nothing to disclose.
Mahesh Jayaraman No disclosure on file
Ali M. Al-Salahat, MBBS Dr. Al-Salahat has nothing to disclose.
Susie Y. Huang, MD, PhD Dr. Huang has received personal compensation in the range of $0-$499 for serving as a Consultant for Siemens Healthineers. The institution of Dr. Huang has received research support from Siemens Healthineers. The institution of Dr. Huang has received research support from Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School.
Lubna E. El Sheikh, Jr., MBBS Dr. El Sheikh has nothing to disclose.
David R. Colelli, MSc Mr. Colelli has nothing to disclose.
Michelle Fullard, MD Dr. Fullard has received research support from Davis Phinney Foundation. Dr. Fullard has received research support from Michael J. Fox Foundation. The institution of Dr. Fullard has received research support from NIH BIRCWH K12. Dr. Fullard has received research support from Lorna G. Moore Faculty Launch Fund.
Alexis N. Simpkins, MD, PhD, MSCR, FAHA, FANA, FÂ鶹´«Ã½Ó³»­ Dr. Simpkins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institute of Neurological Disorders and Stroke Data Safety Monitoring Board. Dr. Simpkins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. The institution of Dr. Simpkins has received research support from NIH/NIA. The institution of Dr. Simpkins has received research support from Bristol-Meyer Squibb Foundation. The institution of Dr. Simpkins has received research support from Corxel. Dr. Simpkins has received publishing royalties from a publication relating to health care.
Naomi Kanazawa Naomi Kanazawa has nothing to disclose.
Roberta Frigerio, MD Dr. Frigerio has nothing to disclose.
Dolora R. Wisco, MD Dr. Wisco has nothing to disclose.
Juntaro Kaneko Juntaro Kaneko has nothing to disclose.
Atsushi Kaneko No disclosure on file
Eric Jackowiak, MD No disclosure on file
Princi Demaisip, MD, RN No disclosure on file
Manuel A. Viamonte, MD No disclosure on file
Helen Rowbotham No disclosure on file
Elham Khalilidehkordi, MD Dr. Khalilidehkordi has nothing to disclose.
Yufan Zhao No disclosure on file
Laura Berman No disclosure on file
Shasha Wu, MD, PhD Dr. Wu has nothing to disclose.
David C. Preston, MD, FÂ鶹´«Ã½Ó³»­ Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Mark I. Boulos, MD, FRCPC, CSCN(EEG), MSc Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision AQ. Dr. Boulos has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Techspert. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sleep Medicine (journal). The institution of Dr. Boulos has received research support from Canadian Institutes of Health Research. The institution of Dr. Boulos has received research support from RLS Foundation. The institution of Dr. Boulos has received research support from Temerty Centre for AI Research and Â鶹´«Ã½Ó³»­ in Medicine (T-CAIREM). The institution of Dr. Boulos has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Boulos has received research support from Alternative Funding Plan from the Academic Health Sciences Centres of Ontario. The institution of Dr. Boulos has received research support from StrokeCog. The institution of Dr. Boulos has received research support from McLaughlin Centre for Molecular Medicine . The institution of Dr. Boulos has received research support from Zoll Itamar. The institution of Dr. Boulos has received research support from Toronto Dementia Research Alliance. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lundbeck.
Myassar Zarif Myassar Zarif has nothing to disclose.
Derryl Miller, MD Dr. Miller has nothing to disclose.
Atif Ghaffar, DO Dr. Ghaffar has nothing to disclose.
Songtam Ngodngamtaweesuk No disclosure on file
Kanokrat Suwanlaong No disclosure on file
Carmen Vizzino No disclosure on file
Carlos Eduardo Vervloet Sollero, MD Dr. Vervloet Sollero has nothing to disclose.
Ryan Verner Ryan Verner has received personal compensation for serving as an employee of LivaNova USA Inc. Ryan Verner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sella Therapies. Ryan Verner has stock in LivaNova PLC.
Andrea Sterenstein, MD Dr. Sterenstein has nothing to disclose.
Antonio Gallo Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis.
Daniel Golan, MD No disclosure on file
Erin D'Agostino, MD Dr. D'Agostino has nothing to disclose.
Katarina B. Dakay, DO No disclosure on file
Sajjad Mueed, MD No disclosure on file
Rola Khodair, MBBS Dr. Khodair has nothing to disclose.
Yasar A. Torres-Yaghi, MD Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Yaghi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Torres-Yaghi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Torres-Yaghi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion .
Nurose Karim, MD Dr. Karim has nothing to disclose.
Boulenouar Mesraoua, MD, FÂ鶹´«Ã½Ó³»­ Dr. Mesraoua has nothing to disclose.
Angela B. Deutschlander, MD No disclosure on file
Galit Alter No disclosure on file
Alon Abraham, MD No disclosure on file
Fahd Amjad, MD Dr. Amjad has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TEVA. Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Amjad has received personal compensation in the range of $0-$499 for serving as a Consultant for abbvie. Dr. Amjad has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Amjad has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyowna Kirin. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for This information is included in the consultant disclosure. The institution of Dr. Amjad has received research support from Roche.
Ivan M. Pavkovic, MD No disclosure on file
Luis G. Manrique, MD Dr. Manrique has nothing to disclose.
Joanna Siuda Joanna Siuda has nothing to disclose.
Kaitlyn Jaenicke No disclosure on file
Virginia Stringel, MD No disclosure on file
Hiroya Ohara, MD Dr. Ohara has nothing to disclose.
Osamah Alnasser, MD Dr. Alnasser has nothing to disclose.
Katherine D. Amodeo, MD The institution of Dr. Amodeo has received research support from Roche. The institution of Dr. Amodeo has received research support from EIP Pharma. The institution of Dr. Amodeo has received research support from Acadia. The institution of Dr. Amodeo has received research support from MJFF. The institution of Dr. Amodeo has received research support from NINDS.
Alma Rechnitzer No disclosure on file
Michael Johnson, PhD No disclosure on file
Ania Busza, MD, PhD Dr. Busza has received research support from NIH/NINDS. Dr. Busza has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Eileen Moran, MD No disclosure on file
Frank Bittner, DO Dr. Bittner has nothing to disclose.
Jared Srinivasan No disclosure on file
Avi A. Algom, MD No disclosure on file
William Rooney, PhD Dr. Rooney has nothing to disclose.
Alan C. Carver, MD No disclosure on file
Ryan A McTaggart No disclosure on file
David A. Stewart, MD No disclosure on file
Lukasz Milanowski, MD Dr. Milanowski has nothing to disclose.
Sanjeev V. Kothare, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kothare has nothing to disclose.
Julia J. Hopyan, MD No disclosure on file
Fen Bao Fen Bao has nothing to disclose.
Mark Gudesblatt, MD The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Andrzej Friedman, MD No disclosure on file
Mahadevappa Mahadevappa No disclosure on file
Sri Raghav S. Sista, MD Dr. Sista has nothing to disclose.
Anna Krygowska-Wajs, MD, PhD No disclosure on file
Swetha Vennavaram, MD Dr. Vennavaram has nothing to disclose.
Rasha Aldabbagh, MD No disclosure on file
Rachel Dorsey No disclosure on file
Amelia L. Heston, MD Dr. Heston has nothing to disclose.
Mohammad Rohani, MD Dr. Rohani has nothing to disclose.
Madeline Bross Ms. Bross has nothing to disclose.
Stella Jensen-Roberts Ms. Jensen-Roberts has nothing to disclose.
Zachary Weinstock Mr. Weinstock has nothing to disclose.
Yi Shen, MD Dr. Shen has nothing to disclose.
Roberto Alejandro Cruz, MD The institution of Dr. Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. The institution of Dr. Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. The institution of Dr. Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AMGEN. The institution of Dr. Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion.
Charles Port, MD No disclosure on file
Harsh Singh No disclosure on file
Tina Oakes Tina Oakes has received personal compensation for serving as an employee of Eli Lilly. Tina Oakes has received stock or an ownership interest from Eli Lilly.
Dulanji Kuruppu, MD Dr. Kuruppu has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Kuruppu has received stock or an ownership interest from Eli Lilly and Company.
Heather Heiser, MD No disclosure on file
Ashley Becker, MD Dr. Becker has nothing to disclose.
Daniel Krashin, MD Dr. Krashin has nothing to disclose.
Joshua Chodosh, MD The institution of Dr. Chodosh has received research support from NIH-NIA. The institution of Dr. Chodosh has received research support from NIH-NINR.
Ferdinand Schweser, PhD Dr. Schweser has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Vijayshree Yadav, MD, FÂ鶹´«Ã½Ó³»­ Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb Foundation. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . The institution of Dr. Yadav has received research support from Department of Veterans Affairs. Dr. Yadav has received research support from NIH. Dr. Yadav has received research support from PCORI. Dr. Yadav has received research support from NMSS. The institution of Dr. Yadav has received research support from Department of Veterans Affairs. The institution of Dr. Yadav has received research support from Tykeson Family Foundation Endowed Professorship.
Fernando L. Pagan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Yuka Terasawa No disclosure on file
Ali Mahta, MD Dr. Mahta has received research support from Brown University Health.
Nataliya Pyatka, MD Dr. Pyatka has nothing to disclose.
Melody Gilroy, BS Ms. Gilroy has nothing to disclose.
Vicki Shanker, MD, FÂ鶹´«Ã½Ó³»­ Dr. Shanker has received personal compensation in the range of $0-$499 for serving as a Consultant for The Insighters.
Frances E. Jensen, MD, FÂ鶹´«Ã½Ó³»­ Dr. Jensen has nothing to disclose.
Dinesh V. Jillella, MD Dr. Jillella has nothing to disclose.
Carlen A. Yuen, MD Dr. Yuen has nothing to disclose.
Bradley M. Klein, MD No disclosure on file
Kelvin L. Chou, MD, FÂ鶹´«Ã½Ó³»­ Dr. Chou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Chou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Chou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevance. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. The institution of Dr. Chou has received research support from NIH. The institution of Dr. Chou has received research support from Parkinson Study Group. The institution of Dr. Chou has received research support from Michael J Fox Foundation. The institution of Dr. Chou has received research support from Cerevance. Dr. Chou has received publishing royalties from a publication relating to health care. Dr. Chou has received publishing royalties from a publication relating to health care.
Victoria Leavitt, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Susan M. Rubin, MD No disclosure on file
Jay D. Varrato, DO Dr. Varrato has nothing to disclose.
Saloni Sharma, MBBS Dr. Sharma has nothing to disclose.
Volkan Tasdemir III, MD No disclosure on file
Tina Jeppesen, MD No disclosure on file
Julien F. Bally, MD No disclosure on file
Rayaz A. Malik, MBBS, PhD Prof. Malik has nothing to disclose.
Betty C. Soliven, MD Dr. Soliven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Pharmacy. The institution of Dr. Soliven has received research support from NIH. The institution of Dr. Soliven has received research support from NIH. The institution of Dr. Soliven has received research support from Alexion. The institution of Dr. Soliven has received research support from Roche/Genentech.
Thomas Wychowski, MD The institution of Dr. Wychowski has received research support from UCB.
Antonio Scalfari, MD Dr. Scalfari has nothing to disclose.
Amy Kuceyeski, PhD An immediate family member of Dr. Kuceyeski has received personal compensation for serving as an employee of Heyer Physical Therapy. The institution of Dr. Kuceyeski has received research support from National Institutes of Health. Dr. Kuceyeski has received personal compensation in the range of $500-$4,999 for serving as a Grant Panel Member with Department of Defense.
Uwe Reuter Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Liily Deutschland. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Uwe Reuter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape . Uwe Reuter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Uwe Reuter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for StreaMEdUp. Uwe Reuter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Uwe Reuter has received research support from Novartis.
Kevin A. Mazurek, PhD Dr. Mazurek has received personal compensation for serving as an employee of Delos Living / Well Living Lab. Dr. Mazurek has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Mazurek has a non-compensated relationship as a Editor with Â鶹´«Ã½Ó³»­ Resident and Fellows Section that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Musab Ali, MD Dr. Ali has nothing to disclose.
Monika Rudzinska-Bar, MD, PhD Dr. Rudzinska-Bar has nothing to disclose.
Matthew J. Hileman, DO No disclosure on file
GRZEGORZ OPALA No disclosure on file
Elaine Lu, MD Ms. Lu has nothing to disclose.
Eli Diamond, MD Dr. Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Biopharmaceuticals. Dr. Diamond has received research support from Applebaum Foundation. Dr. Diamond has received research support from Frame Family Fund. Dr. Diamond has received research support from Joy Family West Foundation.
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Richard H. Swartz, BSc MD PhD FRCPC The institution of Dr. Swartz has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Swartz has received research support from Ontario Brain Institute.
Karl O. Boyle, MD No disclosure on file
Owen A. Ross, PhD Dr. Ross has nothing to disclose.
Irena Rektorova, MD Dr. Rektorova has nothing to disclose.
Barbara Bumstead, NP Ms. Bumstead has nothing to disclose.
Manoj K. Sammi, PhD Dr. Sammi has received research support from Race to Erase MS. Dr. Sammi has received research support from Myelin Repair Foundation. Dr. Sammi has received research support from Revalesio. Dr. Sammi has received research support from Paul G. Allen Family Foundation. Dr. Sammi has received research support from Conrad F Hilton Foundation Innovation Fund. Dr. Sammi has received research support from NIH/NIDDK.
Thais Armangue, MD Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
Yash Shah, MD, MBBS, MPH Dr. Shah has nothing to disclose.
Rebecca L. Tom, MD, MA Dr. Tom has nothing to disclose.
Yarden Bornovski, MD Dr. Bornovski has nothing to disclose.
Ebony Jackson-Shaheed No disclosure on file
Olivia Kaczmarek No disclosure on file
Andrea C. Wasilewski, MD Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals . Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals .
Korhan Buyukturkoglu, PhD Dr. Buyukturkoglu has nothing to disclose.
Michelle Finnegan Michelle Finnegan has received personal compensation for serving as an employee of AbbVie.
Weizhe Li, MD, PhD No disclosure on file
Abigail L. Chua, DO Dr. Chua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Â鶹´«Ã½Ó³»­ Alliance.
Maeve M. Pascoe Kane, MD Ms. Pascoe has nothing to disclose.
Thomas J. Williams, MD Dr. Williams has nothing to disclose.
Shivangi Singh, MD Dr. Singh has nothing to disclose.
Renxin Chu Dr. Chu has nothing to disclose.
Shannon Y. Chiu, MD, MSc Dr. Chiu has received research support from NIH.
Scott Speelziek, MD Dr. Speelziek has nothing to disclose.
Arpan Patel, MBBS Dr. Patel has nothing to disclose.
Richard Wenzel Richard Wenzel has received personal compensation for serving as an employee of Eli Lilly. Richard Wenzel has received stock or an ownership interest from Eli Lilly.
Samson Khachatryan, MD, PhD Dr. Khachatryan has nothing to disclose.
Fransisca Indraswari, MD Dr. Indraswari has nothing to disclose.
Bichun Ouyang Bichum Ouyang has nothing to disclose.
Julia Klein, NP An immediate family member of Ms. Klein has received personal compensation for serving as an employee of Amgen. An immediate family member of Ms. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Kristin M. Galetta, MD Dr. Galetta has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS.
Nobutoshi Morimoto No disclosure on file
Lawanda Esquibel No disclosure on file
Christopher Jensen, PharmD Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
Hwai Y. Ooi, MD Dr. Ooi has nothing to disclose.
Charlie Conway Charlie Conway has received personal compensation for serving as an employee of Biohaven Pharmaceuticals Inc. Charlie Conway has received stock or an ownership interest from Biohaven Pharmaceuticals.
Zachary Scheid, DO No disclosure on file
Laura Ketigian No disclosure on file
Kanitpong Phabphal No disclosure on file
Robert Croop, MD Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Collima LLC. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has stock in Actio Biosciences, Inc. . Dr. Croop has received research support from Pfizer Inc. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
Edith Graham, MD Dr. Graham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Graham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Graham has received research support from F. Hoffman-La Roche Ltd. The institution of Dr. Graham has received research support from Novartis.
Shadi Milani, DO Dr. Milani has nothing to disclose.
Gaurav Thakur, DO Dr. Thakur has nothing to disclose.
Leon Meytin, MD Dr. Meytin has nothing to disclose.
Onyedika Moghalu, MD No disclosure on file
Matthew Vasquez, MD Dr. Vasquez has nothing to disclose.
Bruno I. De Almeida No disclosure on file
Hannah Ferrari No disclosure on file
Kevin Senanayake No disclosure on file
Nandini Abburi, MD Dr. Abburi has nothing to disclose.
Jamie Bolling No disclosure on file
Nirmal Andrapalliyal, MD Dr. Andrapalliyal has nothing to disclose.
Joseph Legacy, MD No disclosure on file
Kathryn P. Moore, MD Dr. Moore has a non-compensated relationship as a Medical Advisory Board with HD Reach that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Quentin Funk Quentin Funk has nothing to disclose.
Mallikarjuna Rettiganti, PhD Dr. Rettiganti has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Rettiganti has received stock or an ownership interest from Eli Lilly and Company.
Sahar Noorani, MD Dr. Noorani has nothing to disclose.
Tigran Khachatryan, MD No disclosure on file
Meixiang Yu No disclosure on file
Anahit C. Mehrabyan, MD Dr. Mehrabyan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UVB. Dr. Mehrabyan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenex.
Patrick Throckmorton No disclosure on file
Mayra Montalvo Perero, MD Dr. Montalvo Perero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG THERAPEUTICS. Dr. Montalvo Perero has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN.
Nilufer Yalcin, MD Dr. Yalcin has nothing to disclose.
Xiao-Tang Kong, MD, PhD Dr. Kong has nothing to disclose.
Akanksha Sharma, MD Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Generation Care Hospice. Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curio Science. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Sharma has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Sharma has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDPI. Dr. Sharma has or had stock in Roon. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Novocure. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Maja Galic Maja Galic has received personal compensation for serving as an employee of Teva.
Hera A. Kamdar, MD Dr. Kamdar has nothing to disclose.
Elyse Stock Elyse Stock has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. An immediate family member of Elyse Stock has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biohaven Pharmaceuticals. An immediate family member of Elyse Stock has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Flagship Pioneering Management. An immediate family member of Elyse Stock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol-Myers Squibb. An immediate family member of Elyse Stock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Optinose. An immediate family member of Elyse Stock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abpro. An immediate family member of Elyse Stock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adagio. Elyse Stock has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Biohaven Pharmaceuticals. Elyse Stock has received stock or an ownership interest from Biohaven Pharmaceuticals. An immediate family member of Elyse Stock has received stock or an ownership interest from BIohaven Pharmaceuticals.
Adena Leder, DO, FÂ鶹´«Ã½Ó³»­ Dr. Leder has nothing to disclose.
Kenzie Brown No disclosure on file
Maryum Shoukat, MD Dr. Shoukat has nothing to disclose.
Ronghua Yang, PhD No disclosure on file
Leah Millsap, PhD Dr. Millsap has nothing to disclose.
Kristopher Southard, MD Dr. Southard has nothing to disclose.
Monica Emili Garcia-Segura No disclosure on file
Dawn Kellar No disclosure on file
Allison Osen, MD Dr. Osen has nothing to disclose.
Terese Gullo, MD Miss Gullo has nothing to disclose.
Lars Oddsson, PhD No disclosure on file
Galina Gheihman, MD Dr. Gheihman has nothing to disclose.